Environmental sensitivities: prevalence of major symptoms in a referral center: the Nova Scotia Environmental Sensitivities Research Center Study. by Joffres, M R et al.
Environmental Health Perspectives • VOLUME 109 | NUMBER 2 | February 2001 161
Environmental Sensitivities: Prevalence of Major Symptoms in a Referral
Center: The Nova Scotia Environmental Sensitivities Research Center Study
Michel R. Joffres,1,2 Tim Williams,3 Brenda Sabo,4 and Roy A. Fox2
1Department of Community Health and Epidemiology, Dalhousie University, Halifax, Nova Scotia, Canada; 2Nova Scotia Environmental
Health Center, Dalhousie University, Fall River, Nova Scotia, Canada; 3OAO Corporation, Corvallis, Oregon, USA; 4Atlantic Health
Promotion Research Center, Dalhousie University, Halifax, Nova Scotia, Canada
Environmental sensitivities (ES) are still con-
sidered by many to be an enigmatic health
concern. Within the medical community,
disparate views on the origins and patho-
physiology abound (1–15). Nevertheless,
individuals continue to experience symp-
toms that produce varying degrees of disabil-
ity. The most frequently cited term to
describe this clustering of medically unex-
plained symptoms has been multiple chemi-
cal sensitivities (MCS), originally coined by
Cullen in his initial paper on workplace
health risks (16). Several theories have been
advanced to explain the diverse symptoms
occurring after exposure to low-level irri-
tants, foods, or electromagnetic radiation
(1,3,4,5–15). 
In the 1995 Nova Scotia Health Survey,
3% of the population reported being envi-
ronmentally sensitive (17). A more recent
study conducted by Kreutzer et al. (18)
stated that 16% of Californians reported
being “allergic or unusually sensitive to
everyday chemicals.” There were no speciﬁc
questions on symptoms other than a list of
products or situations “bothering” or mak-
ing individuals “sick.” In a telephone survey
conducted in North Carolina, Meggs et al.
found that 33% of those surveyed reported
sensitivity to chemicals (19), and 4% of the
total population reported daily or almost
daily frequency of their symptoms. The
most common symptoms among individuals
with chemical sensitivity were nausea (47%),
headache (33%), and eye irritation (16%).
There was no detailed evaluation of symp-
toms in this phone interview survey. Kipen
et al. (20) found a prevalence of sensitivity to
chemicals of 13% among Gulf Registry
Veterans (20). Common within all these
reports was the need to explore further and
more accurately describe this phenomenon.
To answer this need, we used a symp-
tom-based questionnaire to explore the fre-
quency, severity, and type of symptoms
experienced by a Canadian patient popula-
tion referred to a specialty center for envi-
ronmental sensitivities.
Methods
The Nova Scotia Environmental Health
Center is a government-funded facility ded-
icated to research in the context of manage-
ment of individuals referred to the center
by their family physician or another physi-
cian. Conﬁrmation of the diagnosis is based
on symptomatology consistent with ES
(16,21). Alternative reasons for their symp-
toms, such as cancer or other major illness
including major depression or a psychiatric
diagnosis, are routinely ruled out before
their referral and after consultation with the
center physicians. 
A self-administered questionnaire was
mailed between October 1997 and February
1998 to 812 patients of the center who had
been referred for management of ES. A total
of 385 (47%) questionnaires were returned.
Thirty-four participants were not included
in the study because ES were ruled out by
the treating physician, leaving 351 people
for analyses. 
In the questionnaire, a general health
section covered patients’ health status since
the beginning of their illness (ES). The next
section focused on limitations in their daily
activities due to their illness, and a section
on health problems documented major con-
ditions diagnosed by a physician. 
The section on symptoms covered symp-
toms that the patients may have experienced
since the start of their illness, frequency and
intensity of these symptoms, and whether or
not these symptoms occurred or got worse
after identified exposure. Symptoms were
subdivided into 13 categories addressing dif-
ferent organ systems: eye, ear, nose, mouth,
throat, lung, heart and circulation, blood
and gland, muscle and joint, nervous system,
stomach and bowel, bladder and genital, and
skin. At the bottom of each system an
“other” category allowed additional symp-
toms to be listed. A section for women
looked at reproductive systems. A lifestyle
section covered smoking, alcohol intake,
physical activities, and hobbies.
Open-ended questions provided space
for patients to list the type of exposures that
might have been associated with occurrence
of their symptoms. This was followed by
their family history, demographic character-
istics, employment history, socioeconomic
status, and information related to the com-
pletion of the questionnaire.
The Environmental Health Center
Questionnaire was based on the University
of Toronto Health Survey questionnaire
(22,23). Several modifications were made
based on suggestions from the Toronto
investigators and feedback from focus groups
involving patients, from practitioners, and
from pilot testing. Face validity was achieved
by designing the symptoms around the six
definitions of ES (22,23). To restrict the
length of the questionnaire, we placed less
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Although the phenomenon of environmental sensitivities (ES) has no clear etiology nor well-
accepted pathophysiology, affected individuals experience symptoms that cause varying levels of
dysfunction. Through a dedicated, government-funded research and treatment center, a detailed
questionnaire covering 217 symptoms in 13 systems was mailed in 1997–1998 to 812 individuals
referred to the center by physicians. A total of 385 (47%) questionnaires were returned, and data
were analyzed on 351 individuals. Participants tended to be women (80%), middle-aged individ-
uals (37% age 40–49 years), and those in higher educational groups (28% completed university),
but there was wide variation in demographic variables. General symptoms such as difﬁculty con-
centrating, fatigue, forgetfulness, and irritability dominated the overall prevalence of symptoms
since the start of their illness. Those related to irritation such as sneezing, itchy or burning eyes,
and hoarseness or loss of voice were more common after exposure to environmental irritants.
Ranking of symptoms using severity scores was consistent between men and women. Overall
scores were higher in women, in participants who were separated or divorced, and in low-income
groups. The type and consistency of symptoms experienced after exposure to triggering sub-
stances may not ﬁt a purely psychogenic theory. Key words: multiple chemical sensitivities, survey,
symptoms. Environ Health Perspect 109:161–165 (2001). [Online 24 January 2001]
http://ehpnet1.niehs.nih.gov/docs/2001/109p161-165joffres/abstract.htmlemphasis on attempts to identify exposures
that patients perceived as provoking symp-
toms. An open-ended question was added to
provide an opportunity to document per-
ceived exposure–symptom relationships.
Further modifications included changes in
wording from that of the Toronto question-
naire. Complex terminology and politically
sensitive language were avoided. Pilot testing
indicated that the modifications were rele-
vant and reliable. Ethical approval of study
and of consent forms was obtained from the
faculty of medicine ethics committee of
Dalhousie University.
Content validity for the Environmental
Health Center questionnaire was achieved in
several ways. Questions relating to ES were
derived from consultation with ES practi-
tioners and patients. Because recent defini-
tions state that ES are a multisystem,
multisymptom, multifocus health problem
(21), the initial questionnaire was subdivided
into different organ systems to ensure identi-
ﬁcation of those systems involved in the ill-
ness. Additional symptoms were added to
increase content validity after feedback from
patients and clinicians. Demographic and
social variables were obtained from census
questionnaires used by Statistics Canada
Standards Division. Questions on general
health were modeled on those used in previ-
ously validated health surveys (24).
At this point, it is difﬁcult to assess con-
struct validity, predictive validity, and con-
current validity. We evaluated test–retest
reliability for 19 individuals who completed
the same questionnaire after an interval of
approximately 2 weeks. Kappa-values for
each section ranged from 0.6 to 0.8, with
the lowest value being 0.4 for one question.
For the initial Toronto questionnaire,
test–retest reliability showed κ -values around
0.4–0.6 for most systems and overall good
agreement on symptoms (23) .
We computed scores as the frequency of
occurrence of symptoms since the beginning
of the illness (rarely, from time to time, most
of the time, all the time, rated as 1–4) multi-
plied by the severity (low, moderate, high,
rated 1–3). Therefore the maximum score for
each question is 12, the minimum being 0.
The global score is a mean score computed as
the sum of all scores divided by the number
of symptoms. Statistical tests (χ 2 statistic for
proportions and two-sample t-test statistic for
means) were used only for select comparisons
to limit multiple comparison problems and
increase clarity of the tables. Standard errors
are provided to simplify comparisons.
Results
The frequency and proportion of individuals
in each category of selected demographic
characteristics are presented in Table 1. Age
ranged from < 9 years old to > 60 years old.
Thirty-seven percent of the patients were in
the 40–49 age range for both men and
women. A small peak in frequency was seen
in males 10–19 years (20%), but not in
young women. Most men (51%) and
women (67%) were married or in common-
law relationships. A higher but not statisti-
cally significant proportion of women than
men were divorced (11% vs. 4%, p > 0.05),
and a higher proportion of men than women
were never married (37% vs. 17%, p =
0.001). More than one-quarter (28%) had
completed university, with 14% having had
some university training. A higher propor-
tion of women than men (19% vs. 1%, p =
0.001) had completed diploma programs.
Overall, men had a lower education level
than women. Household income distribution
was bimodal, with one peak in the
$20,000–30,000 range and one in the
$80,000+ range.
Table 2 presents the proportion of all
respondents who have the 15 most common
symptoms and how each symptom ranks
compared with the others, between each sex.
The most common 15 symptoms that occur
after an exposure are also presented in the
same table. Symptoms occurring after the
start of illness that may or may not be
related by the patient to some identified
exposure are noted under “in general,” com-
pared to symptoms occurring after an
identified environmental exposure (“after
exposure”). Ranking of these symptoms does
not vary greatly by sex. Ranking of “trouble
finding right words” was higher in women
(8th) than in men (24th) and “stuffy or full
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Table 1. Distribution of selected demographic characteristics of individuals with ES, by sex. 
Both males 
Males Females and females
Characteristics No. % No. % No. %
Age (years)
0–9 5 7 5 2 10 3
10–19 14 20 12 4 26 7
20–29 0 0 9 3 9 3
30–39 14 20 55 20 69 20
40–49 24 34 107 38 131 37
50–59 9 13 72 26 81 23
60+ 4 6 21 7 25 7
All 70 100 281 100 351 100
Marital status
Never married 25 37 47 17 72 21
Separated 1 1 9 3 10 3
Widowed 0 0 3 1 3 1
Married or common-law 35 51 189 67 224 64
Divorced 3 4 30 11 33 9
Other 4 6 3 1 7 2
All 68 100 281 100 349 100
Education
No formal schooling 0 0 2 1 2 1
Some primary 9 13 2 1 11 3
Completed primary 1 1 3 1 4 1
Some secondary  7 10 23 8 30 9
or high school
Completed secondary
or high school 11 16 28 10 39 11
Some college 7 10 14 5 21 6
Completed college 9 13 33 12 42 11
Diploma program 1 1 53 19 54 16
Some university  7 10 40 14 47 14
Completed university 15 22 82 29 97 28
All 67 100 280 100 347 100
Household income
No income 4 6 2 1 6 2
< $6,000 1 2 5 2 6 2
$6,000–$11,999 2 3 22 8 24 7
$12,000–$19,999 4 6 20 7 24 7
$20,000–$29,999 11 18 36 13 47 14
$30,000–$39,999 5 8 41 15 46 14
$40,000–$49,999 12 19 26 9 38 11
$50,000–$59,999 3 5 28 10 31 9
$60,000–$69,999 4 6 17 6 21 6
$70,000–$79,999 – – 12 4 12 4
$80,000 + 7 11 32 12 39 12
No response  9 15 33 12 42 13
All 62 100 274 100 336 100
Column percentages might not add to 100% due to rounding.sinuses” was ranked higher in men (6th)
than in women (21st). Although general
symptoms had dominated the overall preva-
lence of symptoms since the beginning of
their illness, those related to irritation were
more common after exposure. Although
ranking of the first three symptoms was
identical in men and women, women ranked
“hoarse/loss of voice” higher than men (5th
vs. 36th). “Forgetful/poor memory,” “tight
chest,” and “trouble finding right words”
also ranked higher in women than in men
(7th vs. 26th, 8th vs. 22nd, and 10th vs.
31st respectively) while men ranked “usual
odors sickening” and “irritability” higher
than women (7th vs. 12th and 6th vs. 20th
respectively).
Table 3 shows the mean score of the top
five symptoms that had occurred since the
beginning of the illness, in general and after
exposure. Ranking of the symptom score is
presented for each sex. For each category, if a
symptom is ranked in the first five, this
symptom’s rank is presented for the other
sex category. 
The highest overall score for both men
and women was “stronger sense of smell.”
Women ranked fatigue and “tiredness not
relieved by rest or sleep” higher than did
men, while men ranked “less sense of smell”
and “usually acceptable odors were sicken-
ing” higher than did women.
For all the other systems (separate analy-
sis), there were no major differences in the
ranking of the first five symptoms between
men and women. In the nervous system sec-
tion, men ranked “irritability” higher than
did women and “trouble staying asleep”
lower. “Constipation and bloating of stom-
ach” were ranked higher among women than
among men, whereas “heartburn” showed
the opposite pattern.
Different patterns were seen after expo-
sure, with some noticeable differences in
ranking and in mean between sexes. For all
systems, “stronger sense of smell” was ranked
highest for both men and women. “Trouble
seeing at night” was ranked second among
women but ranked very low among men
(84th). On the other hand, men ranked the
following higher than did women: “dark col-
oring of finger tips” (2nd), “bed wetting”
(3rd), “trouble staying asleep” (4th), “snor-
ing or snorting during sleep” (5th), “having
to get up at night to urinate” (6th), and
“joint swelling” (7th) (not all variables
shown in Table 2). Although there were dif-
ferences in ranking between men and
women for each system (separate analysis),
there was an overall consistency in ranking.
Table 4 displays global mean symptom
scores, by sex, for selected demographic vari-
ables. Mean score peaked in the 30–39 age
group for both men and women. For all age
groups men had lower mean scores than
women and a global mean score much lower
than that of women (2.0 vs. 2.7, p = 0.0002
after adjusting for age). Men and women
who were separated/divorced or in the lower
income categories had higher mean scores
than the other groups (p < 0.05).
Discussion
Many articles have argued about the reality
of ES as a single, well-deﬁned medical entity.
The arguments have been summarized by
Sparks et al. (7). A common belief, shared
by some authors, claims that this is an age-
old problem, unsubstantiated by pathophysi-
ological evidence, whose name changes
depending upon current medical and socio-
cultural beliefs. Furthermore, this lack of evi-
dence suggests that the manifestations
should be classified as psychological by
default. Such authors argue that the symp-
toms are psychogenic in nature and cultur-
ally dependent and driven (5,6). First, there
has been relatively little research on this
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Table 2. Prevalence of the top 15 symptoms reported since start of illness and ranked by sex among indi-
viduals with ES.
Both Males Females
Symptoms % Rank % Rank % Rank
In general 
Difﬁculty concentrating  95 1 90 1 96 2
Fatigue, very tired, without energy 95 2 87 3 97 1
Tiredness not relieved by rest or sleep 92 3 84 5 94 3
Sneezing/runny or congested nose without a cold  91 4 90 2 92 5
Forgetfulness/poor memory 90 5 80 9 93 4
Irritability 90 6 85 4 91 6
Other headache 88 7 79 10 90 7
Itchy eye(s) 88 8 81 8 90 9
Trouble ﬁnding the right words 86 9 70 24 90 8
Need to clear throat 85 10 83 7 86 12
Difﬁculty making decisions 84 11 73 16 87 11
Stuffy or full sinuses  83 12 84 6 82 21
Muscle pain or ache not related to overexercise 83 13 79 11 94 17
Stiffness in muscles or joints 83 14 75 13 84 15
Feeling light-headed 82 15 71 18 85 13
After exposure 
Sneezing/runny or congested nose without a cold 66 1 60 1 68 1
Itchy eye(s) 64 2 59 2 65 2
Difﬁculty concentrating 54 3 47 3 56 3
Other headache 52 4 41 8 54 4
Burning eye(s) 50 5 46 4 52 6
Hoarse or loss of voice 49 6 29 36 54 5
Stuffy or full sinuses 46 7 44 5 47 9
Forgetfulness/poor memory 46 8 33 26 49 7
Tight chest 45 9 34 22 48 8
Usually acceptable odors were sickening 44 10 41 7 45 12
Fatigue, very tired, without energy 43 11 40 9 44 15
Difﬁculty making decisions 43 12 34 20 45 11
Trouble ﬁnding the right words 43 13 31 31 46 10
Irritability 43 14 43 6 43 20
Feeling light-headed 43 15 37 11 44 14
“Both” includes males and females; % indicates percent of patients having the symptom; and “rank” is the rank of each
symptom compared with all other symptoms.
Table 3. Top five symptoms scores reported among all systems, by sex, generally or after exposure,
among individuals with ES.
Both Males Females
Symptoms Mean SE Rank Mean SE Rank Mean SE Rank
In general
Stronger sense of smell 8.8 0.21 1 8.9 0.63 1 8.8 0.22 1
Fatigue, very tired, without energy 7.4 0.18 2 6.2 0.40 7 7.7 0.20  2
Tiredness not relieved by 
rest or sleep 7.4 0.18 3 6.4 0.40 5 7.7 0.20 3
Less sense of smell than most people 7.0 0.59 4  7.9 1.31 2 6.7 0.67 9 
Usually acceptable odors were 
sickening 6.7 0.23 5 6.9 0.51 4 6.7 0.25 10
After exposure
Stronger sense of smell 9.6 0.26 1 9.9 0.65 1 9.6 0.29 1
Tiredness not relieved by 
rest or sleep 7.8 0.28 2 7.2 0.65 10 8.0 0.30 2
Trouble seeing at night 7.5 0.59 3 5.0 1.68 84 7.9 0.60 3
Bruise easily 7.3 0.93 4 – – – 7.3 0.93 7
Sensitive to temperature change 7.3 0.59 5 6.9 1.20 13 7.4 0.68 5issue. Second, most of the articles published
contain recycled opinions or rhetoric rather
than data. Controlled studies are rare, and
most of the designs have basic flaws raising
concerns about relevance of conclusions (2).
We are not dealing with a new “disease.”
It is quite remarkable that there has been no
systematic collection of symptoms using a
reliable instrument, and very little in terms
of exploring pathophysiologic theories
(1,7–15,25,26). This lack may be due to the
historical confrontation of clinical ecolo-
gists/environmental medicine physicians
with the rest of the medical establishment.
We examined the prevalence of 217
symptoms in 13 sections/systems. Our study
is the ﬁrst attempt to describe the type, fre-
quency, and severity of the most common
symptoms experienced by an environmen-
tally sensitive population. Outside of the
study by Meggs et al. (19), no research has
been published on a large number of individ-
uals with ES, with a focus on the prevalence
of the most common symptoms. Meggs et al.
looked at the percentage of individuals with
symptoms of allergy and chemical sensitivity,
but on a limited number of symptoms, and
reported only on overall frequency. The
length of the telephone survey may have lim-
ited a more in-depth study of symptoms. 
Environmental sensitivities seem to affect
more women than men (80% vs. 20%), and
women express higher severity scores than
men. This could reﬂect a true biological dif-
ference because other diseases such as
rheumatoid arthritis, systemic lupus erythe-
matosus, scleroderma, multiple sclerosis, and
Sjögren’s syndrome are more common in
women. This difference could also be due to
confounding variables such as socioeconomic
variables or reflect cultural differences
between men and women wherein men
would underreport reactions; or it may sug-
gest that women have more severe reactions
than men. These alternative hypotheses need
to be explored. Although frequency distribu-
tion peaks in the 30–40 age range, ES occur
not just among middle-aged individuals.
Young as well as older individuals are report-
ing symptoms consistent with ES, with 22%
of males who report symptoms being < 20
years old. The higher proportion of men
than women affected in the young age group
remains difficult to explain. Follow-up sur-
veys must be conducted to see whether this
represents a new trend. A concept that has
been commonly held in the literature points
to the absence of ES in older age groups. We
found that approximately 7% of individuals
reporting symptoms consistent with a diag-
nosis of ES were ≥ 60 years old. About 5% of
participants in Kreutzer et al.’s study (18)
had onset of their sensitivity after age 50, and
the average age of people reporting sensitivi-
ties to chemicals in Meggs et al.’s study was
42.4 ± 15.5 years (19). Although most of the
individuals were married, it is interesting to
note that 12% were separated or divorced,
and 21% were never married. In addition,
individuals who are separated have a higher
global score than the other marital categories
(Table 4). This may be the result of increased
stress in the relationships due to ES, although
some authors have hypothesized that
increased difficulties in the relationship
might have led to these symptoms through a
psychogenic mechanism (6). We have
observed both situations at our center.
Increased stressors in individuals’ lives might
be factors predisposing to the occurrence of
ES, potentiating the effect of exposures or
triggers (25,26). 
Another common belief suggests that ES
only affect highly educated individuals.
Although the data show a high proportion of
individuals with postsecondary education
(28% completed university) and above aver-
age income (16% above $70,000), a wide-
spread distribution remains among all
education and income categories, similar to
the findings of Meggs et al. (19). People
with higher education may be more likely to
report symptoms and cognitive problems
affecting their work than people doing man-
ual labor. It is important to note that the
highest global scores are seen in individuals
with a family income < $20,000. Similarly,
Kreutzer et al. (18) found that those with the
higher percentage of indicators of chemical
sensitivity had incomes < $10,000. This may
reflect the loss of employment due to the
severity of the reactions or else sociocultural
and psychological stressors as predisposing
factors in the development of ES.
Day-to-day variations in symptoms and
important variations during the course of ill-
ness create limits to this questionnaire. Some
individuals had difﬁculty thinking about aver-
aging frequency and severity over the course
of their illness. The type of initial exposure(s)
triggering symptoms may also be different
from the substances triggering reactions at
later stages of the illness. Nevertheless, Hu et
al. (27) have found that a brief screening
questionnaire based on exposures could differ-
entiate individuals with ES from controls.
McKeown-Eyssen et al. (23) also found that
the original questionnaire had good agree-
ment on criteria for ES case deﬁnitions (23).
The type of symptoms reported in this
survey—such as difficulty concentrating,
fatigue, forgetfulness, poor memory, irritabil-
ity, trouble ﬁnding the right words, and difﬁ-
culty making decisions—could indicate a
psychogenic origin to these symptoms. The
distribution of symptoms was consistent
between sexes. In addition, the presence and
severity of symptoms were not randomly dis-
tributed. Some symptoms were rare, while
others were not rated high in terms of sever-
ity. Some symptoms such as bed wetting in
men, after exposure, were difﬁcult to predict,
yet were ranked high (separate analysis). It
seems logical to infer that more randomness
in the distributions of symptoms would be
expected in a purely psychogenic origin. It
could be argued that a common psychological
mechanism might lead to speciﬁc symptoms.
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Table 4. Global mean symptoms scores by selected demographic characteristics among individuals with
ES.
Both Males Females
Characteristics Mean SE Mean SE Mean SE
Age (years)
0–9 1.3 0.23 1.2 0.32 1.4 0.37
10–19 1.4 0.15 1.2 0.14 1.6 0.26
20–29 2.1 0.31 – – 2.1 0.31
30–39 3.1 0.16 2.9 0.48 3.1 0.16
40–49 2.7 0.12 2.2 0.26 2.8 0.14
50–59 2.5 0.13 1.9 0.51 2.6 0.13
60+ 2.1 0.19 1.4 0.36 2.2 0.20
All 2.5 0.07 2.0 0.16 2.7 0.08
Marital status
Never married 2.5 0.17 2.0 0.33 2.7 0.20
Married or common-law 2.5 0.09 2.0 0.22 2.6 0.09
Separated/divorced/widowed 2.9 0.18 2.5 0.26 2.9 0.19
Other 1.1 0.16 1.3 0.13 0.8 0.26
Education
Up to some secondary/high school 2.2 0.23 1.7 0.42 2.5 0.26
University degreea 2.5 0.10 2.0 0.22 2.6 0.11
Completed secondary/high school 2.4 0.19 2.2 0.37 2.5 0.23
College or diplomas 2.8 0.12 2.4 0.34 2.9 0.13
Household income
< $20,000 3.0 0.17 2.7 0.44 3.1 0.17
$20,000–$39,999 2.7 0.13 2.3 0.48 2.8 0.13
$40,000 + 2.3 0.11 1.8 0.22 2.4 0.11
No response 2.5 0.18 1.8 0.23 2.7 0.18
aUndergraduate or graduate level.However, this can be questioned because
symptoms experienced after exposure are
commonly associated with irritation.
Davidoff et al. (28) have also shown that the
use of psychometric tests in this population
to attribute symptoms to a psychogenic
cause can be misleading.
In terms of symptoms scores, which refer
to the frequency and intensity of the symp-
toms, “stronger sense of smell” had the high-
est mean, but it was also surprising to see the
high ranking of “less sense of smell than
most people” and “usually acceptable odors
were sickening.” Although the literature
extensively reports on the affected sense of
smell of individuals with ES, the reasons for
this apparent contradiction need to be clari-
ﬁed. Doty (29) quantitatively examined the
olfactory function in patients with MCS and
did not find significant changes in odor
detection threshold to two target stimuli. 
Some of the high scores among women
after exposure such as “trouble seeing at
night” and “bruising easily” were not
expected. The next steps in the analysis of
these data will be to conduct factor analyses
to see if there are any specific subgroups.
Multivariate analysis will be used to investi-
gate associations between symptom occur-
rence, scores, and other variables available in
this data set. In a separate preliminary factor
analysis, a single factor explained a high pro-
portion of variance compared with all the
other factors, suggesting a certain homo-
geneity of this group of individuals.
This study has a few limitations. The rela-
tively low response rate (47%) in this usually
committed group was not anticipated and
limited generalizations. The response rate
might be explained partly by negative media
attention aimed at the center and by a postal
strike, both of which coincided with the mail-
ing of surveys. Follow-up calls to recipients
elicited the following most frequently cited
reasons for failing to answer the question-
naire: difﬁculty answering some of the ques-
tions, length of the questionnaire, busy
lifestyle, or the taxing nature of the question-
naire. Because this population experiences a
high level of cognitive difﬁculties, a long ques-
tionnaire might have been perceived as too
taxing on the already low energy level of some
of these individuals. Pilot testing had not
revealed any major problem in this area, so
the length of the questionnaire had not been
reduced. Because basic demographic data had
been collected on all individuals, comparison
of nonrespondents with respondents found
no statistically signiﬁcant differences in age or
sex distribution between these groups.
Issues around bias due to self-referral and
differential diagnosis were limited because
only Nova Scotia physicians have referred
patients to the center. After examination,
about 9% of referrals received a diagnosis
other than ES. These 34 individuals were
removed from analyses. Because we are the
only referral center in Nova Scotia, we can
also assume that our patient population is
fairly representative of the ES population.
Nevertheless, it is important to recognize
that, as yet, no conclusive test exists to con-
ﬁrm the diagnosis of ES and that a diagno-
sis of ES remains clinical, based on limited
criteria (16,21).
A priori labeling of these symptoms as
psychogenic has done tremendous harm: It
has hindered the ability of affected individu-
als to seek help, and also the amount of
research conducted (7,28,30). It is time to
recognize that we cannot separate the psyche
from the physical dimensions of the human
being, and that we must understand and sup-
port ES sufferers. It is vital not to wait for
answers on deﬁnitions, etiology, and patho-
physiology before we protect individuals with
existing recommendations (31,32). This phe-
nomenon is not new (33); it affects quality of
life, disables, and creates major human and
economic losses. Although many individuals
return to a healthy and productive life, vary-
ing degrees of sensitivity remain. Strategies
that look at multiple aspects of individuals’
lives have been successful in reintegrating
individuals into a fulfilling social and work
environment. Attitudes of treating physicians
must change to reﬂect and accept the reality
of these experiences as multifactorial, where
psychological and physical aspects are part of
the problem and the solution.
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